课题基金 / 基金详情

CORE--PROTEIN AND MOLECULAR BIOLOGY FACILITY

CORE--PROTEIN AND MOLECULAR BIOLOGY FACILITY
核心——蛋白质和分子生物学设施
批准号:
6201112
负责人:
DAVID R KARP
金额:
$17.9万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-09-01 至 1999-09-30

项目摘要

项目成果

DAVID R KARP的其他基金

相似基金

相关文献

中文摘要
翻译
蛋白质和分子和分子生物学的核心课程
英文摘要
The Protein and Molecular and Molecular Biology Core of this Program Project will operate within the existing facilities of the Rheumatic Diseases Division to support the research activities of Program investigators. The research programs proposed by these investigators have common requirements for preparation for reagents, distribution of supplies, synthesis and analysis of nucleic acids, expression of purified proteins and generation of recombinant DNA for in vitro gene transfer experiments and generation of transgenic mice. The Core will consist of a Director, a Research Scientist, and Research Technician. The Core facilities will include a DNA Synthesizer, and Automated DNA Sequencer, long-term tissue culture facilities, and a laboratory for the preparation and purification of recombinant DNA and proteins. The programs and services provided by the Core will be: 1. DNA Synthesis and Sequencing 2. Hybridoma Protein Production 3. Recombinant Protein Production Close collaboration between the Core and the principal investigators for the individual projects will be maintained in order to optimize their research productivity through utilization of Core services. In this way, wasteful redundancy will be avoided, and research reagents will be provided at reduced costs. This will allow centralization of uncommonly used techniques, resulting in better quality control, more rapid throughput.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Study of Anti-Malarials in Incomplete Lupus Erythematosus (SMILE)
Study of Anti-Malarials in Incomplete Lupus Erythematosus (SMILE)
Hydroxychloroquine Treatment for Prevention of Systemic Lupus Erythematosus
Hydroxychloroquine Treatment for Prevention of Systemic Lupus Erythematosus
海外基金